| 30.10 21:11 | MÄRKTE USA/Etwas leichter nach Konjunkturdaten mit Licht und Schatten |
| 30.10 17:16 | MÄRKTE USA/Etwas fester - Eli Lilly und AMD nach Zahlen auf Talfahrt |
| 30.10 14:49 | dpa-AFX: *GE HEALTHCARE +3,2% NACH BIS ZU +5,7% - AN 21-TAGE-LINIE ABGEKEHRT |
| 30.10 14:43 | MÄRKTE USA/Wenig verändert - Eli Lilly knicken nach Zahlen ein |
| 30.10 13:58 | dpa-AFX: *GE HEALTHCARE VORBÖRSLICH +1,2% NACH ZAHLEN - WEITER IN JÜNGSTER SPANNE |
| 30.10 13:53 | MÄRKTE USA/Wenig verändert - Alphabet mit überzeugenden Zahlen |
| 30.10 12:31 | dpa-AFX: GE HealthCare Technologies Q3 24 Earnings Conference Call At 8:30 AM ET |
| 30.10 11:59 | dpa-AFX: ROUNDUP: GE HealthCare Lifts FY24 Adj. Earnings View, Sees Organic Revenue At Lower End Of Range |
| 30.10 11:49 | dpa-AFX: ROUNDUP: GE HealthCare Lifts FY24 Adj. Earnings View; Sees Organic Revenue At Lower End Of Range |
| 30.10 11:30 | dpa-AFX: GE HealthCare Technologies Inc. Q3 Profit Increases, Beats Estimates |
| 30.10 11:26 | dpa-AFX: *GE HEALTHCARE NOW EXPECTS FY24 ORGANIC REVENUE GROWTH OF 1% TO 2% |
| 30.10 11:26 | dpa-AFX: *GE HEALTHCARE NOW EXPECTS FY24 ADJ. EPS OF $4.25 TO $4.35 |
| 30.10 11:25 | dpa-AFX: *GE HEALTHCARE Q3 TOTAL REVENUES $4.863 BLN VS. $4.822 BLN LAST YEAR |
| 30.10 11:24 | dpa-AFX: *GE HEALTHCARE Q3 NET INCOME FROM CONT. OPS. $490 MLN VS $386 MLN LAST YEAR |
| 30.10 11:24 | dpa-AFX: *GE HEALTHCARE Q3 OPERATING INCOME $676 MLN VS. $617 MLN LAST YEAR |
| 30.10 11:23 | dpa-AFX: *GE HEALTHCARE Q3 EPS FROM CONT. OPS. $1.02 VS. $0.83 LAST YEAR |
| 07.10 15:57 | dpa-AFX: GE HealthCare Joins Thera4Care |
| 07.10 15:05 | dpa-AFX: *GE HEALTHCARE LAUNCHES THERA4CARE INITIATIVE TO ENHANCE PATIENT ACCESS TO THERANOSTICS IN EUROPE |
| 07.10 09:26 | dpa-AFX: GE HealthCare Reports Results From Phase 1 Study Of Manganese-based Macrocyclic MRI Contrast Agent |
| 07.10 08:50 | dpa-AFX: *GE HEALTHCARE ANNOUNCES PHASE I RESULTS FOR FIRST-OF-ITS-KIND MANGANESE-BASED MRI CONTRAST AGENT |
|
|
